The Scientist : Fluoroquinolones may reduce the risk of myocardial infarction [3/1/2001]

Front Cover

Advertisement

Front Cover

Survey Series

The Scientist Daily

Science headlines delivered daily.
Register today.

For Advertisers

RESEARCH ROUND-UP

Fluoroquinolones may reduce the risk of myocardial infarction

A history of high doses of fluoroquinolones may bring with it a lower risk of subsequent acute myocardial infarction.

Email: Tudor Toma - ttoma@mail.dntis.ro
News from The Scientist 2001, 2(1):20010103-01

Antibiotic treatment for infections of Chlamydia pneumoniae has been associated with protection against myocardial infarction, probably via a stabilizing effect on the cytoskeleton of endothelial cells and on chondrocytes in humans. Dr Herings et al from the Netherlands decided to test this association through a case-control study to see whether patients receiving antibiotics for Chlamydia pneumoniae infections were less likely to have been admitted for a first acute MI (JAMA 2000 284:2998-2999).


	The article you are attempting to read is Premium content which is only available to our online subscribers.

Subscribing to The Scientist is easy and inexpensive.

And you can choose from many options. Try us out with an online day pass starting at only $4.95. Or, get it all with unlimited online access to The Scientist Archive and door-to-door delivery of our monthly print magazine.


	The Scientist also offers site licenses to institutions and organizations. When your librarian adds The Scientist to the library's collection, you can get unlimited online access through your place of work or study. Recommend The Scientist today